Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Change in Inventory (2020 - 2025)

Bioventus (BVS) has disclosed Change in Inventory for 6 consecutive years, with -$13.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 333.2% year-over-year to -$13.0 million, compared with a TTM value of -$8.6 million through Dec 2025, down 152.14%, and an annual FY2025 reading of -$8.6 million, down 152.14% over the prior year.
  • Change in Inventory was -$13.0 million for Q4 2025 at Bioventus, down from -$291000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $10.0 million in Q4 2022 and bottomed at -$13.0 million in Q4 2025.
  • Average Change in Inventory over 5 years is $1.5 million, with a median of $2.7 million recorded in 2024.
  • The sharpest move saw Change in Inventory surged 1723.93% in 2023, then plummeted 333.2% in 2025.
  • Year by year, Change in Inventory stood at -$1.7 million in 2021, then soared by 692.59% to $10.0 million in 2022, then crashed by 181.34% to -$8.1 million in 2023, then surged by 168.38% to $5.6 million in 2024, then tumbled by 333.2% to -$13.0 million in 2025.
  • Business Quant data shows Change in Inventory for BVS at -$13.0 million in Q4 2025, -$291000.0 in Q3 2025, and $2.8 million in Q2 2025.